GaryDubinMD

PubMed

• 5 citations
  Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
  Htay Htay Han, Naveen Karkada, Girish Jayadeva, Gary Dubin> ;Human Vaccines & Immunotherapeutics. 2017 Jan 2
• 68 citations
  Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-h...
  Suzanne M. Garland, Jorma Paavonen, Unnop Jaisamrarn, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Xavier Castellsagué, Julio Cesar Teixeira, S. Rachel Skinne...> ;International Journal of Cancer. 2016 Dec 15
• 20 citations
  Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
  Matti Lehtinen, Tiina Eriksson, Dan Apter, Mari Hokkanen, Kari Natunen, Jorma Paavonen, Eero Pukkala, Maria-Genalin Angelo, Julia Zima, Marie-Pierre David, Sanjoy K Da...> ;Human Vaccines & Immunotherapeutics. 2016 Nov 14
• 30 citations
  Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
  Agnihotram V. Ramanakumar, Paulo Naud, Cecilia Roteli-Martins, Newton Sérgio de Carvalho, Paola Colares de Borba, Julio Cesar Teixeira, Mark M. Blatter, Anna-Barbara M...> ;BMJ Open. 2016 Aug 1
• 130 citations
  Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-bl...
  Cosette M. Wheeler, S. Rachel Skinner, M. Rowena Del Rosario-Raymundo, Suzanne M. Garland, Archana Chatterjee, Eduardo Lazcano-Ponce, Jorge Salmerón, Shelly A. McNeil,...> ;The Lancet. Infectious Diseases. 2016 Oct 1
• 64 citations
  Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
  S. Rachel Skinner, Cosette M. Wheeler, Barbara Romanowski, Xavier Castellsagué, Eduardo Lazcano-Ponce, M. Rowena Del Rosario-Raymundo, Carlos S. Vallejos, Galina Minki...> ;International Journal of Cancer. 2016 May 15
• Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
  Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David M, Wheeler CM, González P, Jiménez S, Lowy DR, Pinto...> ;Lancet Oncol.. 2015-07-01
• 38 citations
  Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial
  Matti Lehtinen, Dan Apter, Iacopo Baussano, Tiina Eriksson, Kari Natunen, Jorma Paavonen, Simopekka Vänskä, Dan Bi, Marie-Pierre David, Sanjoy K Datta, Frank Struyf, D...> ;Vaccine. 2015 Mar 3
• 78 citations
  Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of ...
  Dan Apter, Cosette M. Wheeler, Jorma Paavonen, Xavier Castellsagué, Suzanne M. Garland, S. Rachel Skinner, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Henry C Kitchener...> ;Clinical and Vaccine Immunology. 2015 Feb 4
• 132 citations
  Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, d...
  S. Rachel Skinner, Anne Szarewski, Barbara Romanowski, Suzanne M. Garland, Eduardo Lazcano-Ponce, Jorge Salmerón, M. Rowena Del Rosario-Raymundo, René H.M. Verheijen, ...> ;Lancet. 2014 Dec 20
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against incident and persistent infection with non-vaccine oncogenic HPV types using an alternativ...
  Struyf, F.,Colau, B.,Wheeler, C. M.,Naud, P.,Garland, S.,Quint, W.,Chow, S.,Salmerón, J.,Lethinen, M.,Del Rosario-Raymundo, M. R.,Paavonen, J.,Teixeira, J. C.,Germar, ...> ;Clin. Vaccine Immunol.. 2014 Dec 30
• 90 citations
  Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 ye...
  Mark H. Einstein, Peter Takacs, Archana Chatterjee, Rhoda S. Sperling, Nahida Chakhtoura, Mark M. Blatter, Jacob Lalezari, Marie-Pierre David, Lan Lin, Frank Struyf, G...> ;Human Vaccines & Immunotherapeutics. 2014 Nov 1
• 47 citations
  Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged...
  Mark H. Einstein, Myron J. Levin, Archana Chatterjee, Nahida Chakhtoura, Peter Takacs, Grégory Catteau, Francis Dessy, Philippe Moris, Lan Lin, Frank Struyf, Gary Dubi...> ;Human Vaccines & Immunotherapeutics. 2014 Nov 1
• 28 citations
  Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRI...
  Xavier Castellsagué, Jorma Paavonen, Unnop Jaisamrarn, Cosette M. Wheeler, S. Rachel Skinner, Matti Lehtinen, Paulo Naud, Song-Nan Chow, Maria Rowena Del Rosario-Raymu...> ;BMC Infectious Diseases. 2014 Oct 30
• 24 citations
  Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
  Terry Nolan, Sumita Roy-Ghanta, May Montellano, Lily Yin Weckx, Rolando Ulloa-Gutierrez, Eduardo Lazcano-Ponce, Angkool Kerdpanich, Marco Aurélio Palazzi Sáfadi, Aurel...> ;The Journal of Infectious Diseases. 2014 Aug 15
• 83 citations
  Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
  Allan Hildesheim, Sholom Wacholder, Grégory Catteau, Frank Struyf, Gary Dubin, Rolando Herrero> ;Vaccine. 2014 Sep 3
• 18 citations
  Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from ...
  Pierre Van Damme, Geert Leroux-Roels, Philippe Simon, Jean-Michel Foidart, Gilbert G.G. Donders, Karel Hoppenbrouwers, Myron J. Levin, Fabian Tibaldi, Sylviane Poncele...> ;Vaccine. 2014 Jun 17
• Risk of newly detected infections and cervical abnormalities in women seropositive for naturally-acquired HPV-16/18 antibodies: analysis of the control arm of PATRICIA.
  Castellsagué, X.,Naud, P.,Chow, S. N.,Wheeler, C. M.,Germar, M. J.,Lehtinen, M.,Paavonen, J.,Jaisamrarn, U.,Garland, S. M.,Salmerón, J.,Apter, D.,Kitchener, H.,Teixeir...> ;J. Infect. Dis.. 2014 Mar 13
• 14 citations
  Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial
  Remon Abu-Elyazeed, Thomas C. Heineman, Gary Dubin, Marc Fourneau, Isabel Leroux-Roels, Geert Leroux-Roels, Jan Hendrik Richardus, Lars Østergaard, Javier Díez-Domingo...> ;Vaccine. 2013 Dec 9
• 64 citations
  Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
  Anne Szarewski, S. Rachel Skinner, Suzanne M. Garland, Barbara Romanowski, Tino F. Schwarz, Dan Apter, Song Nan Chow, Jorma Paavonen, M. Rowena Del Rosario-Raymundo, J...> ;The Journal of Infectious Diseases. 2013 Nov 1
• 36 citations
  Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
  Gary Dubin, Jean-François Toussaint, Jean-Pol Cassart, Barbara Howe, Donna Boyce, Leonard R. Friedland, Remon Abu-Elyazeed, Sylviane Poncelet, Htay Htay Han, Serge Debrus> ;Human Vaccines & Immunotherapeutics. 2013 Aug 28
• 9 citations
  Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine.
  Fernanda Tavares, Brigitte Cheuvart, Thomas C. Heineman, Felix Arellano, Gary Dubin> ;Vaccine. 2013 Mar 25
• 16 citations
  Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: a double-blind randomized trial.
  Geert Leroux-Roels, Frédéric Clement, Pierre Vandepapelière, Marc Fourneau, Thomas C. Heineman, Gary Dubin> ;Human Vaccines & Immunotherapeutics. 2013 Feb 22
• 180 citations
  Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women
  David I. Bernstein, Abbie R. Bellamy, Edward W. Hook, Myron J. Levin, Anna Wald, Marian G. Ewell, Peter A. Wolff, Carolyn Deal, Thomas C. Heineman, Gary Dubin, Robert ...> ;Clinical Infectious Diseases. 2013 Feb 1
• 28 citations
  Occurrence of vaccine and non‐vaccine human papillomavirus types in adolescent Finnish females 4 years post‐vaccination
  Johanna Palmroth, Marko Merikukka, Jorma Paavonen, Dan Apter, Tiina Eriksson, Kari Natunen, Gary Dubin, Matti Lehtinen> ;International Journal of Cancer. 2012 Dec 15
• Join now to see all